Transparency Market Research Report Added “ Acute Ischemic Stroke Diagnosis and
Treatment Market (By Diagnostics Type - CT, MRI, Ultrasound, Cerebral Angiography, Nuclear Imaging and Others By Surgery Type - Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) " to its database. Acute Ischemic Stroke Diagnosis and Treatment Market: Discription Acute ischemic stroke can be defined as interruption of blood supply to the brain due to the blockage of blood vessel due to atherosclerosis plaques or blood clots in the artery. Acute ischemic stroke can caused due to thrombotic or embolic occlusion of cerebral artery. This research report on acute ischemia diagnosis and treatment market explains various advancements occurring in this market and analyzes the global acute ischemic stroke diagnosis and treatment market by diagnosis types and surgery types as well as geographic regions. This report comprises of an elaborate executive summary, which includes a market snapshot that provides a market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram which is drawn that reflects the market size of various segments in descending order. Browse Market Research Report: http://www.transparencymarketresearch.com/acute-ischemic-stroke-treatment.html The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnosis such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, cerebral angiography, nuclear imaging and others. The market for these diagnosis types has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the manufacturers. The market size and forecast in terms of USD million for each diagnosis type has been provided for the period 2012 to 2020. The report on the acute ischemic stroke diagnosis and treatment market also provides % compounded annual growth rate (CAGR) for each of the aforementioned market segment for the forecast period 2014 to 2020, considering 2013 as the base year. Acute Ischemic Stroke Diagnosis and Treatment Market: Overview Acute ischemic stroke can be defined as loss of function in certain parts of brain due to lack or disturbance in the blood supply to the brain. This is usually caused by atherosclerosis plaques blocking blood vessels, narrowing of blood vessels, or blood clots
closing off blood supply to or from arteries feeding the brain. Technological advancements in surgical devices coupled with rising prevalence of acute ischemia stroke cases collectively accentuates the global demand of surgical procedures in acute stroke treatment. Similarly, aging population, increased demand for minimally invasive procedures and rise in healthcare spending has triggered the growth of this segment market. However, excessive usage of medication for the treatment of ischemic stroke is anticipated to hinder the global market growth of surgery for acute stroke. The global acute ischemic stroke diagnosis and treatment market was valued at USD 1,225.0 million in 2013 and is expected to grow at a CAGR of 6.3% from 2014 to 2020, to reach an estimated value of USD 1,869.7 million by 2020. Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1799 The global market for acute ischemic stroke diagnosis and treatment is segmented based on diagnostics type as CT, MRI, ultrasound, cerebral angiography, nuclear imaging and others. In 2013, CT segment accounted for the largest market share of the global acute ischemic stroke diagnosis and treatment market owing to efficient and effective detection, easy availability and strong demand of CT in the global market. Moreover, MRI is expected to grow at the highest CAGR compared with all diagnostic device types during the forecast period due to its increasing popularity.
Table of Contents Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Assumptions 1.4 List of Abbreviations Chapter 2 Executive Summary 2.1 Overview 2.2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020)
2.3 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types , 2013 (USD Million) 2.4 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 and 2020 (Value %) Chapter 3 Market Overview 3.1 Overview 3.2 Event Impact Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market 3.3 Market Drivers 3.3.1 Rising number of acute stroke patients aiding the growth of diagnosis and treatment market 3.3.2 Technological innovations in diagnostic and surgical devices boosts market growth 3.4 Restraints 3.4.1 Alternative treatments and high cost are posing a threat for the growth of the market 3.5 Opportunities 3.5.1 Huge potential patient in Asia-Pacific creates opportunity for acute ischemic stroke product developers record high growth in revenue 3.6 Value Chain Analysis 3.7 Porter’s Five Force Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market 3.7.1 Bargaining power of suppliers 3.7.2 Bargaining power of buyers 3.7.3 Threat of new entrants 3.7.4 Threat of substitutes 3.7.5 Competitive rivalry 3.8 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography
3.9 Competitive Landscape 3.9.1 Market Share Analysis by Key Players, 2013 (Value %) Chapter 4 Acute Diagnostic Type
Ischemic
Stroke
Diagnosis
and
Treatment
Market,
by
4.1 Overview 4.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million) 4.2 Computed Tomography 4.2.1 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million) 4.3 Magnetic Resonance Imaging 4.3.1 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million) 4.4 Ultrasound 4.4.1 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million) 4.5 Cerebral angiography 4.5.1 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million) 4.6 Nuclear Imaging 4.6.1 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million) 4.7 Others 4.7.1 Global Others Market Revenue, 2012 – 2020 (USD Million) Chapter 5 Acute Ischemic Stroke Diagnosis and Treatment Market by, Surgery Type 5.1 Overview 5.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million) 5.2 Carotid Endarterectomy 5.2.1 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million)
5.3 Angioplasty 5.3.1 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million) 5.4 Endovascular Mechanical Thrombectomy 5.4.1 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million) Chapter 6 Geography
Acute
Ischemic
Stroke
Diagnosis
and
Treatment
Market,
by
6.1 Overview 6.1.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million) 6.2 North America 6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) 6.3 Europe 6.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) 6.4 Asia-Pacific 6.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) 6.5 Rest of the World 6.5.1 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) Chapter 7 Recommendations 7.1 Rigorous research and development initiatives for innovative products 7.2 Investing in emerging economies Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview
8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Covidien plc 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Johnson & Johnson (Cordis Corporation) 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Penumbra, Inc. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 Philips Healthcare 8.5.1 Company Overview
8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 GE Healthcare 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Hitachi, Ltd. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Siemens Healthcare 8.8.1 Company Overview 8.8.2 Financial overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Stryker Corporation (Concentric Medical, Inc.) 8.9.1 Company Overview
8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments List of Figures FIG. 1 Acute Ischemic Stroke Diagnosis and Treatment: Market Segmentation FIG. 2 Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Types, 2013 (USD Million) FIG. 3 Comparative Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 & 2020 (Value %) FIG. 5 Porter’s Five Forces Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market FIG. 6 Market Attractiveness Analysis: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2013 Value (%) FIG. 7 Market Share Analysis: Acute Ischemic Stroke Diagnosis and Treatment Market, 2013 (Value %) FIG. 8 Global Computed Tomography Market Revenue, 2012 – 2020 (USD Million) FIG. 9 Global Magnetic Resonance Imaging Market Revenue, 2012 – 2020 (USD Million) FIG. 10 Global Ultrasound Market Revenue, 2012 – 2020 (USD Million) FIG. 11 Global Cerebral Angiography Market Revenue, 2012 – 2020 (USD Million) FIG. 12 Global Nuclear Imaging Market Revenue, 2012 – 2020 (USD Million) FIG. 13 Global Others Market Revenue, 2012 – 2020 (USD Million) FIG. 14 Global Carotid Endarterectomy Market Revenue, 2012 – 2020 (USD Million) FIG. 15 Global Angioplasty Market Revenue, 2012 – 2020 (USD Million) FIG. 16 Global Endovascular Mechanical Thrombectomy Market Revenue, 2012 – 2020 (USD Million) FIG. 17 North America Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) FIG. 19 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) FIG. 20 RoW Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, 2012 – 2020 (USD Million) FIG. 21 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million) FIG. 22 Covidien plc: Annual Revenue, 2011 – 2013 (USD Million) FIG. 23 Johnson & Johnson: Annual Revenue, 2011 – 2013 (USD Million) FIG. 24 Philips Healthcare: Annual Revenue,2011 – 2013 (USD Million) FIG. 25 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million) FIG. 26 Hitachi, Ltd.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 27 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million) FIG. 28 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) List of Tables TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Acute Ischemic Stroke Diagnosis and Treatment Market (2013 & 2020) TABLE 3 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Diagnostic Types, 2012 – 2020 (USD Million) TABLE 4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Surgery Type, 2012 – 2020 (USD Million) TABLE 5 Global Acute Ischemic Stroke Diagnosis and Treatment Market Revenue, by Geography, 2012 – 2020 (USD Million) About Us Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e
proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Each
TMR
Syndicated
Research
report
covers
a
different
sector
–
such
as
pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement. Contact Transparency Market Research 90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com Browse market research blog: https://tmrresearch.blogspot.com/